Leap Therapeutics Secures $58.88 Million for Digital Asset Strategy

According to Foresight News, biotechnology company Leap Therapeutics, listed on NASDAQ under the ticker LPTX, has announced a $58. 88 million private placement led by Winklevoss Capital. This funding aims to initiate a digital asset financial strategy. Winklevoss Capital will provide both financial and strategic support to assist Leap in developing and implementing its digital asset strategy source: https://www.binance.com/en/square/post/30651301169378?utm_source=BinanceNewsRSS